Doctor profile · Federal record

Dr. Ray Lin

Medical Physician Assistant (CMS: Physician Assistant) · Medical Physician Assistant · Riverside, CA

  • NPI 1649693540
  • Accepts Medicare
  • 13 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
9041 Magnolia Ave, 206
Riverside, CA 925033900
(951) 354-2220

Credentials & registration

NPPES · NUCC
NPI registered
January 2014 — 12 yrs on file
Profile last updated
July 21, 2016
Year of graduation
2013 — 13 yrs since
Specialty taxonomy
363AM0700X — NUCC code
State licenses (2)
California #51415 · Texas #PA08998

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1649693540. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
786
Distinct HCPCS
10
Medicare allowed
$42,835
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 360 48 $6
99214 Established patient office or other outpatient visit, 30-39 minutes 111 77 $113
17000 Destruction of precancer skin growth, 1 growth 63 52 $40
17110 Destruction of skin growth, 1-14 growths 61 51 $103
99213 Established patient office or other outpatient visit, 20-29 minutes 40 36 $80
11102 Biopsy of related skin growth, first growth 39 36 $71
99204 New patient office or other outpatient visit, 45-59 minutes 36 36 $146
17004 Destruction of precancer skin growth, 15 or more growths 32 27 $153
99203 New patient office or other outpatient visit, 30-44 minutes 24 24 $99
11103 Biopsy of related skin growth, each additional growth 20 14 $45

In context: peer comparison

Among 7 peers in Riverside Medical Physician Assistant, average services per provider: 311. This provider delivers 2.5× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,370
Transactions
104
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Dermavant Sciences, INC. 22 $1,022.06
Genzyme Corporation 12 $553.24
Regeneron Healthcare Solutions, INC. 9 $318.89
Abbvie INC. 15 $288.38
Amgen INC. 9 $276.44
DePuy Synthes Sales INC. 2 $252.81
Novartis Pharmaceuticals Corporation 13 $237.93
Leo Pharma INC. 12 $181.95
E.R. Squibb & Sons, L.L.C. 2 $91.94
Janssen Biotech, INC. 3 $53.87
Arcutis Biotherapeutics, INC. 1 $21.90
Galderma Laboratories, L.P. 1 $21.44
Sun Pharmaceutical Industries INC. 1 $19.92
Lilly USA, LLC 1 $15.46
Pfizer INC. 1 $14.02

By nature of payment

Food and Beverage
$3,370

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,842
Patients
903
Total drug cost
$240,664
Drug Type Claims Patients Total cost
Ketoconazole Generic 402 171 $7,738
Triamcinolone Acetonide Generic 345 188 $4,448
Clobetasol Propionate Generic 325 144 $20,397
Fluocinonide Generic 180 100 $11,027
Clindamycin Phosphate Generic 85 35 $3,244
Fluorouracil Generic 75 60 $4,949
Doxycycline Hyclate Generic 71 37 $1,274
Ciclopirox Generic 69 25 $1,563
Mupirocin Generic 55 42 $385
Hydrocortisone Generic 45 24 $285

Frequently asked questions

Auto-generated from federal data
What is Dr. Ray Lin's medical specialty?
Dr. Ray Lin practices Medical Physician Assistant in Riverside, CA.
Where does Dr. Ray Lin practice?
Dr. Ray Lin practices at 9041 Magnolia Ave, Riverside, CA 925033900. Office phone: 9513542220.
What is Dr. Ray Lin's NPI?
Dr. Ray Lin's National Provider Identifier (NPI) is 1649693540, issued by NPPES.
Does Dr. Ray Lin accept Medicare assignment?
Yes. Dr. Ray Lin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ray Lin commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.